Insider Transactions in Q3 2024 at Natera, Inc. (NTRA)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Indirect |
19,300
-7.28%
|
$2,451,100
$127.73 P/Share
|
|
Sep 18
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
2,700
-0.47%
|
$342,900
$127.72 P/Share
|
|
Sep 16
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
5,024
-0.51%
|
$643,072
$128.84 P/Share
|
|
Sep 13
2024
|
Rowan E Chapman |
SELL
Open market or private sale
|
Direct |
2,614
-24.7%
|
$331,978
$127.68 P/Share
|
|
Sep 13
2024
|
Rowan E Chapman |
BUY
Exercise of conversion of derivative security
|
Direct |
2,614
+19.81%
|
$245,716
$94.14 P/Share
|
|
Aug 15
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
12,000
-4.01%
|
$1,452,000
$121.01 P/Share
|
|
Aug 15
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
5,583
-1.36%
|
$664,377
$119.4 P/Share
|
|
Aug 13
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
3,956
-3.34%
|
$458,896
$116.67 P/Share
|
|
Aug 12
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+7.78%
|
-
|
|
Aug 12
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
2,700
-0.22%
|
$307,800
$114.42 P/Share
|
|
Aug 08
2024
|
Matthew Rabinowitz EXECUTIVE CHAIRMAN |
BUY
Exercise of conversion of derivative security
|
Direct |
190,000
+11.37%
|
$950,000
$5.4 P/Share
|
|
Jul 31
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,866
-2.53%
|
$184,734
$99.65 P/Share
|
|
Jul 31
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
100
+0.09%
|
$500
$5.4 P/Share
|
|
Jul 29
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,238
-1.65%
|
$126,276
$102.77 P/Share
|
|
Jul 29
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
4,084
-1.94%
|
$416,568
$102.77 P/Share
|
|
Jul 29
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
929
-0.85%
|
$94,758
$102.77 P/Share
|
|
Jul 29
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
1,196
-1.05%
|
$121,992
$102.77 P/Share
|
|
Jul 29
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,057
-0.51%
|
$107,814
$102.77 P/Share
|
|
Jul 26
2024
|
Roy D. Baynes |
BUY
Grant, award, or other acquisition
|
Direct |
143
+0.9%
|
-
|
|
Jul 26
2024
|
Roelof Botha |
BUY
Grant, award, or other acquisition
|
Direct |
234
+6.16%
|
-
|
|
Jul 26
2024
|
James Healy |
BUY
Grant, award, or other acquisition
|
Direct |
177
+0.38%
|
-
|
|
Jul 26
2024
|
Herm Rosenman |
BUY
Grant, award, or other acquisition
|
Direct |
206
+0.31%
|
-
|
|
Jul 26
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
751
-0.99%
|
$76,602
$102.18 P/Share
|
|
Jul 25
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
690
-0.9%
|
$72,450
$105.29 P/Share
|
|
Jul 24
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
918
-1.19%
|
$96,390
$105.53 P/Share
|
|
Jul 23
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
499
-0.64%
|
$53,393
$107.4 P/Share
|
|
Jul 22
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,059
-1.34%
|
$111,195
$105.16 P/Share
|
|
Jul 22
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+1.56%
|
-
|
|
Jul 22
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
815
-0.39%
|
$85,575
$105.16 P/Share
|
|
Jul 22
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
2,638
-1.24%
|
$276,990
$105.16 P/Share
|
|
Jul 22
2024
|
John Fesko PRESIDENT, CHIEF BUS. OFFICER |
SELL
Open market or private sale
|
Direct |
549
-0.5%
|
$57,645
$105.16 P/Share
|
|
Jul 22
2024
|
Solomon Moshkevich PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct |
549
-0.48%
|
$57,645
$105.16 P/Share
|
|
Jul 21
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,145
+1.45%
|
-
|
|
Jul 21
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
644
+0.31%
|
-
|
|
Jul 21
2024
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
143
+0.05%
|
-
|
|
Jul 21
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
1,774
+0.83%
|
-
|
|
Jul 20
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,522
+1.95%
|
-
|
|
Jul 20
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
856
+0.41%
|
-
|
|
Jul 20
2024
|
Jonathan Sheena |
BUY
Exercise of conversion of derivative security
|
Direct |
190
+0.06%
|
-
|
|
Jul 20
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
BUY
Exercise of conversion of derivative security
|
Direct |
3,386
+1.58%
|
-
|
|
Jul 15
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
5,496
-1.29%
|
$610,056
$111.91 P/Share
|
|
Jul 01
2024
|
Michael Burkes Brophy CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,983
-6.23%
|
$538,164
$108.37 P/Share
|
|
Jul 01
2024
|
Steven Leonard Chapman CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct |
37,500
-5.19%
|
$4,050,000
$108.59 P/Share
|
|
Jul 01
2024
|
Daniel Rabinowitz SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,723
-1.3%
|
$294,084
$108.37 P/Share
|
|
Jul 01
2024
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct |
2,700
-0.44%
|
$291,600
$108.98 P/Share
|